These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 23092271)

  • 1. Overcoming the blood-brain barrier for chemotherapy: limitations, challenges and rising problems.
    Wang Z; Sun H; Yakisich JS
    Anticancer Agents Med Chem; 2014; 14(8):1085-93. PubMed ID: 23092271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug delivery strategies to enhance the permeability of the blood-brain barrier for treatment of glioma.
    Zhang F; Xu CL; Liu CM
    Drug Des Devel Ther; 2015; 9():2089-100. PubMed ID: 25926719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The blood-brain/tumor barriers: challenges and chances for malignant gliomas targeted drug delivery.
    Zhan C; Lu W
    Curr Pharm Biotechnol; 2012 Sep; 13(12):2380-7. PubMed ID: 23016643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Image-guided chemotherapy with specifically tuned blood brain barrier permeability in glioma margins.
    Gao X; Yue Q; Liu Y; Fan D; Fan K; Li S; Qian J; Han L; Fang F; Xu F; Geng D; Chen L; Zhou X; Mao Y; Li C
    Theranostics; 2018; 8(11):3126-3137. PubMed ID: 29896307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted brain delivery nanoparticles for malignant gliomas.
    Pinto MP; Arce M; Yameen B; Vilos C
    Nanomedicine (Lond); 2017 Jan; 12(1):59-72. PubMed ID: 27876436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overcoming the blood-brain tumor barrier for effective glioblastoma treatment.
    van Tellingen O; Yetkin-Arik B; de Gooijer MC; Wesseling P; Wurdinger T; de Vries HE
    Drug Resist Updat; 2015 Mar; 19():1-12. PubMed ID: 25791797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood-Brain Barrier- and Blood-Brain Tumor Barrier-Penetrating Peptide-Derived Targeted Therapeutics for Glioma and Malignant Tumor Brain Metastases.
    Chen L; Zeng D; Xu N; Li C; Zhang W; Zhu X; Gao Y; Chen PR; Lin J
    ACS Appl Mater Interfaces; 2019 Nov; 11(45):41889-41897. PubMed ID: 31615203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functionalized liposomes: an enticing nanocarrier for management of glioma.
    Peddinti V; Rout B; Agnihotri TG; Gomte SS; Jain A
    J Liposome Res; 2024 Jun; 34(2):349-367. PubMed ID: 37855432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotherapy Delivery Strategies to the Central Nervous System: neither Optional nor Superfluous.
    Drapeau A; Fortin D
    Curr Cancer Drug Targets; 2015; 15(9):752-68. PubMed ID: 26077730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mustard-inspired delivery shuttle for enhanced blood-brain barrier penetration and effective drug delivery in glioma therapy.
    Wang N; Sun P; Lv M; Tong G; Jin X; Zhu X
    Biomater Sci; 2017 May; 5(5):1041-1050. PubMed ID: 28378865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comprehensive review in improving delivery of small-molecule chemotherapeutic agents overcoming the blood-brain/brain tumor barriers for glioblastoma treatment.
    Wang D; Wang C; Wang L; Chen Y
    Drug Deliv; 2019 Dec; 26(1):551-565. PubMed ID: 31928355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting Brain Tumors with Nanomedicines: Overcoming Blood Brain Barrier Challenges.
    Khaitan D; Reddy PL; Ningaraj N
    Curr Clin Pharmacol; 2018; 13(2):110-119. PubMed ID: 29651960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liposome-based glioma targeted drug delivery enabled by stable peptide ligands.
    Wei X; Gao J; Zhan C; Xie C; Chai Z; Ran D; Ying M; Zheng P; Lu W
    J Control Release; 2015 Nov; 218():13-21. PubMed ID: 26428462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual kinin B1 and B2 receptor activation provides enhanced blood-brain barrier permeability and anticancer drug delivery into brain tumors.
    Côté J; Savard M; Neugebauer W; Fortin D; Lepage M; Gobeil F
    Cancer Biol Ther; 2013 Sep; 14(9):806-11. PubMed ID: 23792591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced therapeutic agent delivery through magnetic resonance imaging-monitored focused ultrasound blood-brain barrier disruption for brain tumor treatment: an overview of the current preclinical status.
    Liu HL; Yang HW; Hua MY; Wei KC
    Neurosurg Focus; 2012 Jan; 32(1):E4. PubMed ID: 22208897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of permeability, doxorubicin delivery, and drug retention in a rat brain tumor model after ultrasound-induced blood-tumor barrier disruption.
    Park J; Aryal M; Vykhodtseva N; Zhang YZ; McDannold N
    J Control Release; 2017 Mar; 250():77-85. PubMed ID: 27742444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug delivery to brain tumours: challenges and progress.
    Ningaraj NS
    Expert Opin Drug Deliv; 2006 Jul; 3(4):499-509. PubMed ID: 16822225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MR image-guided delivery of cisplatin-loaded brain-penetrating nanoparticles to invasive glioma with focused ultrasound.
    Timbie KF; Afzal U; Date A; Zhang C; Song J; Wilson Miller G; Suk JS; Hanes J; Price RJ
    J Control Release; 2017 Oct; 263():120-131. PubMed ID: 28288892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Penetrating the Blood-Brain Barrier by Self-Assembled 3D DNA Nanocages as Drug Delivery Vehicles for Brain Cancer Therapy.
    Tam DY; Ho JW; Chan MS; Lau CH; Chang TJH; Leung HM; Liu LS; Wang F; Chan LLH; Tin C; Lo PK
    ACS Appl Mater Interfaces; 2020 Jul; 12(26):28928-28940. PubMed ID: 32432847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring Therapeutic Advancement and Strategies Associated with Drug Delivery in Brain-Tumor Targeting.
    Stephen BJ; Sharma MM; Jain D; Dhaliwal H; Sharma V; Singh A
    Crit Rev Ther Drug Carrier Syst; 2021; 38(2):1-25. PubMed ID: 33639066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.